Siemens Healthineers AG (OTCMKTS:SMMNY) Stock Short Interest Report for October

Siemens Healthineers AG (OTCMKTS:SMMNY) was the target of a significant decrease in short interest in October. As of October 30th, there was short interest totaling 7,112 shares, a decrease of 89.8% from the October 15th total of 69,756 shares. Based on an average daily trading volume, of 66,210 shares, the days-to-cover ratio is currently 0.1 days.

Wall Street Analysts Forecast Growth

Several research analysts have commented on SMMNY shares. Royal Bank Of Canada reissued an “outperform” rating on shares of Siemens Healthineers in a research note on Friday, October 16th. Zacks Research cut shares of Siemens Healthineers from a “hold” rating to a “strong sell” rating in a research note on Thursday, October 1st. Deutsche Bank reaffirmed a “hold” rating on shares of Siemens Healthineers in a report on Tuesday, August 18th. Finally, Citigroup reiterated a “buy” rating on shares of Siemens Healthineers in a research report on Tuesday, October 13th. One analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, Siemens Healthineers has an average rating of “Moderate Buy”.

Siemens Healthineers Stock Performance

Shares of OTCMKTS:SMMNY traded up $0.15 during midday trading on Friday, hitting $24.22. 16,118 shares of the stock traded hands, compared to its average volume of 124,949. The business’s 50 day moving average is $22.70 and its two-hundred day moving average is $21.92. Siemens Healthineers has a one year low of $19.20 and a one year high of $27.46.

About Siemens Healthineers

Siemens Healthineers AG is a Germany-based medical technology company that develops products, services and digital solutions for healthcare providers. Its portfolio supports diagnostic, therapeutic and monitoring activities across hospitals, clinics, laboratories and other healthcare settings. The company’s offerings include magnetic resonance imaging, computed tomography, X-ray, molecular imaging and ultrasound systems, as well as laboratory diagnostics, point-of-care testing and related software.